CDKN2A, BIRC5, and SPP1 expression levels were significantly upregulated in tumor tissues (p < 0.001) (Fig. 5A–H), while IGF1 expression was considerably downregulated (p < 0.001). This evidence concerns the gene CDKN2A and neoplasm.